Australia, June 5 -- UCB Biosciences Inc., owns the trademark (2630723) for 'KYGEVVI' till Jan. 16, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of tk2 gene diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders.]
Type of Mark: Fancy
Date of Acceptance: March 27
Registration Advertised: June 4
For further details contact Kumiko Ide Wenderoth, Lind & Ponack LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2630723.
Disclaimer: Curated by HT Syndication.
